Hysensbio
Innovative therapeutics for dental disease based on cell activation technology
Gwacheon, South Korea · Founded 2016 · $3.6M raised
- Headquarters
- Gwacheon
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- hysensbio.com
- Total Funding
- $3.6M
- Last Round
- $2.0M Venture RoundMay 2026
- Rounds
- 3
About
HysensBio is a South Korean biotechnology company founded in 2016 by Professor Ju-Cheol Park of Seoul National University School of Dentistry. The company develops innovative therapeutic products for dental diseases based on over 20 years of foundational dental research. HysensBio's core technology focuses on odontoblast (dental pulp cell) activation and periodontal ligament fibroblast activation, enabling treatments for dental hypersensitivity (sensitive teeth), dental caries, and periodontal disease. Its lead candidate KH-001 is in Phase 2 clinical trials in the United States for dental hypersensitivity, with additional pipeline programs for periodontal tissue regeneration. HysensBio is headquartered in Gwacheon, Gyeonggi-do, South Korea, and has received recognition including the IR52 Jang Young-shil Award for technology innovation and the 2025 Prime Minister's Award for venture startup promotion.
Summary
Hysensbio is a Biotech company based in Gwacheon, South Korea, founded in 2016. It has raised $3.6M in total across 3 rounds, most recently a $2.0M Venture Round round in May 2026. Investors include Korea Investment Partners, Orion Capital Asia and KB Investment.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2026
Sign up to see all 3 rounds
Venture Round — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/hysensbio"><img src="https://indexed.vc/api/badge/company/hysensbio" alt="Hysensbio on Indexed.vc" width="260" height="76" /></a>